US2001000085A1PendingUtilityA1
Formaldehyde scavenging in microbiocidal articles
Priority: Sep 13, 1996Filed: Nov 30, 2000Published: Apr 5, 2001
Est. expirySep 13, 2016(expired)· nominal 20-yr term from priority
Inventors:Gang Sun
D06M 13/358D06M 16/00D06M 13/432D06M 13/364D06M 13/352A61L 2300/204A01N 25/10A61L 2300/404D06M 15/423D06M 11/09A01N 59/00A61L 2300/202A01N 25/34D06M 13/355A61L 31/16A61L 15/46
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Improved methods for durable and regenerable antimicrobial finishing of fabrics are disclosed. In certain embodiments, the methods reduce the amount of free-formaldehyde released during processing by using a formaldehyde scavenger such as a polyol. The improved process imparts regenerable antimicrobial functions to cellulose articles including textiles, papers, wood pulp, and any cellulose-containing materials. The treated product acquire antimicrobial properties after being treated with a halogenated solution.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A process for preparing a microbiocidal article with a reduction in free-formaldehyde release, said process comprising:
(a) immersing said article in an aqueous treating solution which comprises a heterocyclic amine and a polyol; and (b) treating said article with a halogenated solution, thereby rendering said article microbiocidal with a reduction in free-formaldehyde release.
2 . The process according to claim 1 , wherein said aqueous treating solution further comprises a catalyst and a wetting agent.
3 . The process according to claim 1 , wherein said heterocyclic amine is alkylated or partially alkylated.
4 . The process according to claim 1 , wherein said polyol is a member selected from the group consisting of ethylene glycol, propylene glycol, diethylene glycol, 1,2-propylene glycol, 1,3-propylene glycol, 1,2-butylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, polyethylene glycols having the formula HO(CH 2 CH 2 O) n H wherein n is about 1 to about 50, glycerin and combinations thereof.
5 . The process according to claim 4 , wherein said polyol is ethylene glycol.
6 . The process according to claim 4 , wherein said polyol is diethylene glycol.
7 . The process according to claim 1 , wherein said heterocyclic amine and said polyol are present in said treating solution in a heterocyclic amine:polyol ratio between about 0.2:1.0 to about 1.0:6.0 mole/mole.
8 . The process according to claim 7 , wherein said heterocyclic amine:polyol ratio is about 0.5:1.0 to about 1.0:3.0 mole/mole.
9 . The process according to claim 1 , wherein said heterocyclic amine is a member selected from the group consisting of monomethylol-5,5-dimethylhydantoin (MDS), 1,3-dimethylol-5,5-dimethylhydantoin (DMDMH), 5,5-dimethylhydantoin (DMH); monoalkylolated and dialklylolated derivatives of 2,2,5,5-tetramethytl-1,3-imidazolidin-4-one, 6,6-dimethyl-1,3,5-triazine-2,4-dione, 4,4,5,5-tetramethyl-1,3-imidazolidin-2-one, cyanuric acid and 5,5-dimethylhydantoin (DMH); and monoalkylated and dialkylated derivatives of monoalkylolated and dialkylolated derivatives of 2,2,5,5-tetramethyl-1,3-imidazolidin4-one, 6,6-dimethyl-1,3,5-triazine-2,4-dione, 4,4,5,5-tetramethyl-1,3-imidazolidin-2-one, cyanuric acid, 5,5-dimethylhydantoin, 2,2,5,5-tetramethyl-1,3-imidazolidin-4-one, an alkylated derivative thereof and mixtures thereof.
10 . The process according to claim 9 , wherein said heterocyclic amine is 1,3-dimethylol-5,5-dimethylhydantoin (MDMH) or an alkylated derivative thereof.
11 . The process according to claim 9 , wherein said heterocyclic amine is monomethylol-5,5-dimethylhydantoin (MDMH) or an alkylated derivative thereof.
12 . The process according to claim 11 further comprising dimethyloldihydroxyethylene urea (DMDHEU) or an alkylated derivative thereof.
13 . The process according to claim 10 , further comprising dimethyloldihydroxyethylene urea (DMDHEU) or an alkylated derivative thereof.
14 . The process according to claim 11 , further comprising dimethyloldihydroxyethylene urea (DMDHEU) or an alkylated derivative thereof.
15 . The process according to claim 10 , further comprising 5,5-dimethylhydantoin (DMH).
16 . The process according to claim 11 , further comprising 5,5-dimethylhydantoin (DMH).
17 . The process of claim 1 , further comprising removing excess aqueous treating solution from said article before treating said article with a halogenated aqueous solution.
18 . The process of claim 17 , further comprising drying said article after removing excess aqueous treating solution to produce a dried article.
19 . The process of claim 18 , further comprising curing said dried article to produce a cured article.
20 . The process of claim 19 , further comprising washing said cured article to remove excess reagents.
21 . The process of claim 20 , further comprising drying said washed article to remove water.
22 . The process of claim 1 , wherein said article is a textile.
23 . The process of claim 22 , wherein said textile is a member selected from the group consisting of cellulosic fabric, cellulosic yarn, and cellulosic fiber.
24 . The process of claim 22 , wherein said textile is cotton fabric.
25 . The process of claim 22 , wherein said textile is cotton fabric/polyester blend.
26 . The process of claim 1 , wherein said article is a polymer.
27 . The process of claim 26 , wherein said polymer is a member selected from the group consisting of cellulose and a synthetic polymer.
28 . The process of claim 1 , wherein said halogenated aqueous solution comprises sodium hypochlorite.
29 . The process of claim 1 , wherein said catalyst is a member selected from the group consisting of Catalyst 531, MgCl 2 , Mg(NO 3 ) 2 , Zn(NO 3 ) 2 and NH 4 NO 3 .
30 . A process for preparing a microbiocidal article with a reduction in free-formaldehyde release, said process comprising:
(a) immersing said article in an aqueous treating solution which comprises an alkylated heterocyclic amine; and (b) treating said article with a halogenated solution, thereby rendering said article microbiocidal with a reduction in free-formaldehyde release.
31 . The process according to claim 30 , wherein said alkylated heterocyclic amine is alkylated or partially alkylated 1,3-dimethylol-5,5-dimethylhydantoin (DMDMH).
32 . The process according to claim 30 , wherein said alkylated heterocyclic amine is alkylated or partially alkylated monomethylol-5,5-dimethylhydantoin (MDMH).
33 . The process according to claim 30 , wherein said aqueous treating solution further comprises a catalyst and a wetting agent.Join the waitlist — get patent alerts
Track US2001000085A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.